MedTrace Logo

A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma

NCT05852028 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2023-05-10

No results posted yet for this study

Summary

This study aims to observe and explore the efficacy and safety of selinexor-based regimen in patients with Non-Hodgkin lymphoma

Conditions

Interventions

DRUG

Selinexor

this is a real-world. Patients who use selinexor-based regimens in lymphoma will be followed up without interfering with the choice of treatment options for patients

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-15
Primary Completion
2024-10-10
Completion
2025-10-18

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05852028 on ClinicalTrials.gov